Document is current
Any future updates will be listed below
-
Authors
Jedrzejczyk, Johannes H. https://orcid.org/0000-0001-5029-9117
Andersen, Frederik T. https://orcid.org/0009-0000-5605-1673
Petersen, Jacob
Kaspersen, Alexander Emil https://orcid.org/0000-0002-6088-5248
Sahana, Urjosee
Skov, Søren N. https://orcid.org/0000-0003-2352-853X
Væsel, Jens T.
Hasenkam, J. Michael https://orcid.org/0000-0001-7960-1172
Tjørnild, Marcell J. https://orcid.org/0000-0002-4772-4319
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF20OC0065584)
Aarhus University Hospital
- License Information
-
More Information
Article History
Received: 14 June 2024
Accepted: 18 October 2024
First Online: 28 October 2024
Declarations
:
: No human subjects were included in this study. All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the Danish Inspectorate of Animal Experimentation (No. 2016–15-0201–01132).
: The authors declare that they have no conflict of interest. The small intestinal submucosa extracellular matrix (CorMatrix®) was provided free of charge from the manufacturer. The company did not influence study design or interpretation of data. They have not influenced or approved the content of this manuscript.
